Published in Schizophr Res Treatment on October 30, 2013
Comprehensive family therapy: an effective approach for cognitive rehabilitation in schizophrenia. Neuropsychiatr Dis Treat (2015) 0.78
A power primer. Psychol Bull (1992) 63.66
The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07
Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull (2000) 9.62
A modified card sorting test sensitive to frontal lobe defects. Cortex (1976) 6.86
A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry (2011) 5.21
A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry (2007) 4.78
Schizophrenia. Lancet (2004) 4.70
Child and adolescent mental health worldwide: evidence for action. Lancet (2011) 3.79
The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull (2009) 3.78
Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry (1999) 3.69
Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior. Arch Gen Psychiatry (2004) 2.61
Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. Am J Psychiatry (2001) 2.04
Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol (2005) 1.96
Information processing and attention dysfunctions in schizophrenia. Schizophr Bull (1993) 1.91
The effects of neurocognitive remediation on executive processing in patients with schizophrenia. Schizophr Bull (1999) 1.89
A review of cognitive training in schizophrenia. Schizophr Bull (2003) 1.83
Childhood cognitive functioning in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophr Bull (2000) 1.78
A meta-analysis of cognitive deficits in adults with a diagnosis of schizophrenia. Neuropsychol Rev (2005) 1.78
The construct of attention in schizophrenia. Biol Psychiatry (2008) 1.68
Memory rehabilitation in Alzheimer's disease: a review of progress. Int J Geriatr Psychiatry (2001) 1.67
Bridging the gaps between research, policy and practice in low- and middle-income countries: a survey of health care providers. CMAJ (2010) 1.58
Cognitive remediation in schizophrenia. Neuropsychol Rev (2009) 1.58
Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Comparisons with controls or patients with schizophrenia. Arch Gen Psychiatry (1995) 1.55
Defining a cognitive function decrement in schizophrenia. Biol Psychiatry (2005) 1.47
Memory strategy development: do we need yet another deficiency? Child Dev (2001) 1.46
What is the best approach to treating schizophrenia in developing countries? PLoS Med (2007) 1.39
Nonparametric analysis of ordinal data in designed factorial experiments. Phytopathology (2004) 1.36
Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectancies. Schizophr Bull (2006) 1.30
Packages of care for schizophrenia in low- and middle-income countries. PLoS Med (2009) 1.08
Insight, cognitive dysfunction and symptomatology in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2008) 0.94
Effects of Attention Process Training on cognitive functioning of schizophrenic patients. Psychiatry Res (2003) 0.92
Psychiatric rehabilitation and its present role in developing countries. World Psychiatry (2006) 0.92
Cognitive remediation therapy in schizophrenia: cost-effectiveness analysis. Schizophr Res (2010) 0.89
Cost of schizophrenia: direct costs and use of resources in the State of São Paulo. Rev Saude Publica (2006) 0.87
Setting priorities for mental health research in Brazil. Rev Bras Psiquiatr (2012) 0.86
The role of the World Psychiatric Association in facilitating development of psychiatric publications from low-and middle-income countries. Rev Bras Psiquiatr (2012) 0.85
Time to rehospitalization in patients with schizophrenia discharged on first generation antipsychotics, non-clozapine second generation antipsychotics, or clozapine. Psychiatry Res (2011) 0.84
Neuropsychological profile of cognitively impaired patients with schizophrenia. Compr Psychiatry (2006) 0.83
Cross-cultural adaptation, reliability and validity of the DAFS-R in a sample of Brazilian older adults. Arch Clin Neuropsychol (2010) 0.83
Neuropsychological rehabilitation in the treatment of schizophrenia. Conn Med (1997) 0.82
Psychosocial rehabilitation in developing countries. Int Rev Psychiatry (2012) 0.79
A preliminary controlled trial of cognitive behavioral therapy in clozapine-resistant schizophrenia. J Nerv Ment Dis (2009) 0.79
The Modified Card Sorting Test: test-retest stability and relationships with demographic variables in a healthy older adult sample. Br J Clin Psychol (1998) 0.78
Concession of sickness benefit to social security beneficiaries due to mental disorders. Rev Bras Psiquiatr (2011) 0.76
Evaluation of the factors interfering with drug treatment compliance among Brazilian patients with schizophrenia. Rev Bras Psiquiatr (2005) 0.91
Lithium as a treatment of clozapine-induced neutropenia: a case report. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.91
Clinical aspects of super-refractory schizophrenia: a 6-month cohort observational study. Rev Bras Psiquiatr (2007) 0.88
Understanding tDCS effects in schizophrenia: a systematic review of clinical data and an integrated computation modeling analysis. Expert Rev Med Devices (2014) 0.87
Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia: a double-blind study. Schizophr Res (2004) 0.84
Aripiprazole for patients with schizophrenia and schizoaffective disorder: an open-label, randomized, study versus haloperidol. CNS Spectr (2009) 0.82
A 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia. BMC Psychiatry (2013) 0.80
Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study. Curr Med Res Opin (2013) 0.80
Structural brain abnormalities in early-onset schizophrenia. Arq Neuropsiquiatr (2006) 0.77
Validation of a treatment algorithm for major depression in an older Brazilian sample. Int J Geriatr Psychiatry (2012) 0.77
The psychopathological factors of refractory schizophrenia. Rev Bras Psiquiatr (2005) 0.76
Investigation of possible association between Ser9Gly polymorphism of the D3 dopaminergic receptor gene and response to typical antipsychotics in patients with schizophrenia. Sao Paulo Med J (2006) 0.76
Refractory psychotic symptoms in a patient with homozygous sickle cell disease: a 24-month follow-up. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.75